1-6 of 6
Paul La Rosée, MD
Close
Sort by
Journal Articles

Therapy of Acquired Aplastic Anemia (AA) with Rabbit Antithymocyte Globulin (rATG): A Retrospective Analysis by the Working Group on Non-Malignant Disorders of Hematopoiesis of the German Society of Hematology and Oncology (DGHO),

Britta Höchsmann, MD, Christiane Neher, Ulrich Germing, MD, Janne Vehreschild, MD, Juliane Eggermann, MD, Dietrich Braumann, MD, Bernd Hertenstein, MD, Anke Franzke, MD, Karin Mayer, MD, Paul La Rosée, MD, Stefan Wilop, MD, Karl-Heinz Pflueger, MD, Hans-Josef Weh, MD, Bernd Gruhn, MD, Alfred Leipold, MD, Mark Ringhoffer, MD, Heinz A. Duerk, MD, Kumar Sinah, MD, Aristoteles Giagounidis, MD, Hubert Schrezenmeier, MD
Journal: Blood
Blood (2011) 118 (21): 3434.
https://doi.org/10.1182/blood.V118.21.3434.3434
Published: 2011
Journal Articles

Harmonized Testing for BCR-ABL Kinase Domain Mutations In CML: Results of a Survey and First Control Round within 28 National Reference Laboratories In Europe

Thomas Ernst, MD, Feng Lin, PhD, Helen E White, PhD, Paul La Rosée, MD, Thomas Lion, MD, PhD, Gerlinde Mitterbauer-Hohendanner, MD, Peter Vandenberghe, MD, PhD, Renata Zadro, MD, PhD, Katerina Machova Polakova, PhD, Radek Plachy, PhD, Charlotte Guldborg Nyvold, M.Sci., Ph.D., Tuija Lundán, PhD, Jean-Michel Cayuela, PhD, Thoralf Lange, MD, Martin C. Müller, Katerina Zoi, MD, PhD, Hajnalka Andrikovics, MD, PhD, Tali Tohami, MD, PhD, Fabrizio Pane, MD, Simona Soverini, Francesca Arruga, PhD, Lene Eggen, PhD, Tomasz Sacha, MD, Joana Diamond, MD, PhD, Rodica Talmaci, MD, PhD, Tadej Pajic, MD, PhD, Dolors Colomer, MD, PhD, Monica Hermanson, PhD, Elisabeth Oppliger Leibundgut, PhD, Peter J. M. Valk, PhD, Ugur Ozbek, MD, PhD, Gareth Gerrard, PhD, Giuseppe Saglio, MD, PhD, Andreas Hochhaus, MD, Nicholas C.P. Cross, PhD, FRCPath
Journal: Blood
Blood (2010) 116 (21): 894.
https://doi.org/10.1182/blood.V116.21.894.894
Published: 2010
Journal Articles

Monitoring of Phosphorylated CRKL in Imatinib Resistant Patients with BCR-ABL Positive Leukemias Expressing BCR-ABL Mutants Treated with AMN107.

Paul La Rosée, MD, Susanne Holm-Eriksen, Thomas Ernst, MD, Heiko König, MD, Philipp Erben, MD, Martin Müller, MD, Thomas Schenk, MD, Michael Emig, MD, Anja Binckebanck, MD, Lydia Wunderle, MD, Leila Alland, MD, Peter Schuld, MD, Rüdiger Hehlmann, MD, Oliver G. Ottmann, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2005) 106 (11): 497.
https://doi.org/10.1182/blood.V106.11.497.497
Published: 2005
Journal Articles

Selective Inhibition of Lysophosphatidic Acid Acyltransferase-β by CT32228 Inhibits MAPK and Enhances the Antileukemic Activity of Imatinib in BCR-ABL Expressing Cell Lines Resistant to Imatinib.

Paul La Rosée, MD, Taiping Jia, BS, Shadmehr Demehri, Peter de Vries, PhD, Lynn Bonham, PhD, Junia V. Melo, MD, PhD, Jack W. Singer, MD, PhD, Brian J. Druker, MD, Michael W. Deininger, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1524.
https://doi.org/10.1182/blood.V106.11.1524.1524
Published: 2005
Journal Articles

Early Detection of Imminent Hematologic Relapse Due to BCR-ABL Kinase Domain Mutations in CML Patients on Imatinib Therapy by D-HPLC.

Thomas Ernst, MD, Philipp Erben, MD, Thomas Schenk, MD, Martin C. Mueller, MD, Michael Emig, MD, Sebastian Kreil, MD, Paul La Rosée, MD, Ute Berger, MD, Ruediger Hehlmann, MD, Andreas Hochhaus, MD
Journal: Blood
Blood (2005) 106 (11): 1088.
https://doi.org/10.1182/blood.V106.11.1088.1088
Published: 2005
Journal Articles

Glutathione-Depletion Potently Enhances the Cytotoxic Activity of Arsenic Trioxide in Imatinib Sensitive and Resistant Bcr-Abl Positive Cell Lines.

Heiko Koenig, MD, Erika M. Moseson, MA, Christian Lorentz, MD, Peter Paschka, MD, Junia V. Melo, MD, PhD, Ruediger Hehlmann, MD, Andreas Hochhaus, MD, Paul La Rosée, MD
Journal: Blood
Blood (2004) 104 (11): 2098.
https://doi.org/10.1182/blood.V104.11.2098.2098
Published: 2004